1. Home
  2. MRUS vs TKC Comparison

MRUS vs TKC Comparison

Compare MRUS & TKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • TKC
  • Stock Information
  • Founded
  • MRUS 2003
  • TKC 1993
  • Country
  • MRUS Netherlands
  • TKC Turkey
  • Employees
  • MRUS N/A
  • TKC N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • TKC Telecommunications Equipment
  • Sector
  • MRUS Health Care
  • TKC Telecommunications
  • Exchange
  • MRUS Nasdaq
  • TKC Nasdaq
  • Market Cap
  • MRUS 5.1B
  • TKC 5.2B
  • IPO Year
  • MRUS 2016
  • TKC 2000
  • Fundamental
  • Price
  • MRUS $95.18
  • TKC $5.85
  • Analyst Decision
  • MRUS Buy
  • TKC
  • Analyst Count
  • MRUS 18
  • TKC 0
  • Target Price
  • MRUS $93.72
  • TKC N/A
  • AVG Volume (30 Days)
  • MRUS 1.9M
  • TKC 2.2M
  • Earning Date
  • MRUS 10-31-2025
  • TKC 11-06-2025
  • Dividend Yield
  • MRUS N/A
  • TKC 4.04%
  • EPS Growth
  • MRUS N/A
  • TKC N/A
  • EPS
  • MRUS N/A
  • TKC 0.27
  • Revenue
  • MRUS $56,606,000.00
  • TKC $4,477,789,455.00
  • Revenue This Year
  • MRUS $52.81
  • TKC $41.27
  • Revenue Next Year
  • MRUS N/A
  • TKC $29.26
  • P/E Ratio
  • MRUS N/A
  • TKC $8.67
  • Revenue Growth
  • MRUS 57.54
  • TKC 1.16
  • 52 Week Low
  • MRUS $33.19
  • TKC $5.35
  • 52 Week High
  • MRUS $95.30
  • TKC $7.63
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 78.45
  • TKC 47.66
  • Support Level
  • MRUS $94.75
  • TKC $5.76
  • Resistance Level
  • MRUS $95.10
  • TKC $5.99
  • Average True Range (ATR)
  • MRUS 0.34
  • TKC 0.07
  • MACD
  • MRUS -0.91
  • TKC -0.01
  • Stochastic Oscillator
  • MRUS 86.67
  • TKC 49.52

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.

Share on Social Networks: